IP Library Granted Patent US 12,150,952
Granted Patent B2
US 12,150,952 · App. 15/734,847 · Granted Nov 26, 2024

Formulation for the use in the simultaneous treatment of coccidial infections and iron deficiencies

Inventors: Stefan Hofmann (Langenfeld, DE); Kirsten Borngen (Feldhasenweg, DE); Maya Vinzing (Hosfelds Katernberg, DE)
Assignee: Elanco Animal Health GmbH
A61K31/715A61K9/0019A61K9/0053A61K31/53A61K47/10A61K47/12A61K47/26A61K47/32A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,150,952
App. No.
15/734,847
Granted
Nov 26, 2024
Kind
B2
Abstract

The present invention relates to a formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies containing a triazinone such as toltrazuril and a polynuclear iron(III) polysaccharide complex compound together with a specifically selected surfactant that has a hydrophilic-lipophilic-balance (HLB) value of ≥10.

Claims (8)

1. A method for simultaneous treatment of coccidial infections and iron deficiencies in a non-human animal, the method comprising administering to the non-human animal a formulation comprising toltrazuril or diclazuril, a polynuclear iron(III) polysaccharide complex compound and at least two surfactants having a HLB value of 10 or more,

wherein the at least two surfactants are Polysorbate 20 and Polysorbate 80.

2. The method according to claim 1 , wherein the formulation is a suspension.

3. The method according to claim 1 , wherein the formulation is orally administered.

4. The method according to claim 1 , wherein the formulation is parenterally administered.

5. The method according to claim 4 wherein the formulation is administered by injection.

6. The method according to claim 1 , wherein the formulation further comprises sodium chloride.

7. A method for simultaneous treatment of coccidial infections and iron deficiencies in a non-human animal, the method comprising administering to the non-human animal a formulation comprising toltrazuril, iron dextran glucoheptanoate, phenol, polysorbate 20, polysorbate 80, sodium chloride, and water.

Assignments (2)
CHANGE OF NAME Recorded Jul 31, 2024
From: BAYER ANIMAL HEALTH GMBH
To: ELANCO ANIMAL HEALTH GMBH
Reel/Frame 068219/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2022
From: HOFFMAN, STEFAN; BORNGEN, KIRSTEN; MAYA, VINZING
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 061313/0854 →
Priority Claims (1)
EP 18176138 · Jun 5, 2018 · regional
Continuity (1)
Related Publication 20210228612A1 · Jul 29, 2021